Recall archive / FDA drug enforcement
Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Dist... — FDA record D-0641-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jul 11, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by: Aurohealth LLC, 279 Princeton-Hightstown Road, East Windsor, NJ , Made in India, NDC 58602-882-21.
- Reason
- Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
- Classification
- Class I
- Recalling firm
- Aurobindo Pharma USA Inc
- Quantity
- 240 bottles
- Agency-reported status
- Ongoing
- Source record identifier
- D-0641-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot#: AC2523005A, Exp 6/30/2025 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
NJ, NY & PA
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Aug 28, 2024
- Recall initiation date
- Jul 11, 2024
- Center classification date
- Aug 20, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.